Paper34864950
Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network.
Bukkems VE and 13 others. Clin Infect Dis, 2022. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network. Papers, record 34864950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34864950
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| HIV Infections | Major topic |
| Adenine | |
| Alanine | |
| Female | |
| HIV | |
| Humans | |
| Pregnancy | |
| Pregnant People | |
| Tenofovir |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16176115 | Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/16176115 | PubMed |
| 2 | 25959631 | Pharmacokinetics of tenofovir during pregnancy and postpartum. | HIV Med | 2015 | https://conductscience.org/library/papers/25959631 | PubMed |
| 3 | 26640223 | Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus. | Antiviral Res | 2016 | https://conductscience.org/library/papers/26640223 | PubMed |
| 4 | 28971607 | Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide. | Pharmacol Res Perspect | 2017 | https://conductscience.org/library/papers/28971607 | PubMed |
| 5 | 23807155 | Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults. | J Acquir Immune Defic Syndr | 2013 | https://conductscience.org/library/papers/23807155 | PubMed |
| 6 | 33252495 | Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV. | AIDS | 2021 | https://conductscience.org/library/papers/33252495 | PubMed |
| 7 | 30783649 | Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/30783649 | PubMed |
| 8 | 29435666 | Pregnancy- Associated Changes in Pharmacokinetics and their Clinical Implications. | Pharm Res | 2018 | https://conductscience.org/library/papers/29435666 | PubMed |
| 9 | 24872136 | Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study. | J Acquir Immune Defic Syndr | 2014 | https://conductscience.org/library/papers/24872136 | PubMed |
| 10 | 21089008 | Performance of estimated glomerular filtration rate prediction equations in preeclamptic patients. | Am J Perinatol | 2011 | https://conductscience.org/library/papers/21089008 | PubMed |
| 11 | 23169329 | The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women. | AIDS | 2013 | https://conductscience.org/library/papers/23169329 | PubMed |
| 12 | 25890673 | Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. | Lancet | 2015 | https://conductscience.org/library/papers/25890673 | PubMed |
| 13 | 15855512 | Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15855512 | PubMed |
| 14 | 32330231 | Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Network. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/32330231 | PubMed |
| 15 | 30815689 | Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide. | J Antimicrob Chemother | 2019 | https://conductscience.org/library/papers/30815689 | PubMed |
| 16 | 23601190 | A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. | BMC Pediatr | 2013 | https://conductscience.org/library/papers/23601190 | PubMed |
| 17 | 24508897 | Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults. | J Antimicrob Chemother | 2014 | https://conductscience.org/library/papers/24508897 | PubMed |
| 18 | 22850510 | Cobicistat boosts the intestinal absorption of transport substrates, including HIV protease inhibitors and GS-7340, in vitro. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22850510 | PubMed |
| 19 | 33812487 | Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. | Lancet | 2021 | https://conductscience.org/library/papers/33812487 | PubMed |
| 20 | 32115202 | Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care. | Semin Perinatol | 2020 | https://conductscience.org/library/papers/32115202 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42687587 | Predicting Oral HIV Pre-Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42687587 | PubMed |
| 42090286 | Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy. | J Antimicrob Chemother | 2026 | https://conductscience.org/library/papers/42090286 | PubMed |
| 41222898 | Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/41222898 | PubMed |
| 40413716 | An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate. | Drugs R D | 2025 | https://conductscience.org/library/papers/40413716 | PubMed |
| 39487018 | Care of Pregnant Women Living with Human Immunodeficiency Virus. | Clin Perinatol | 2024 | https://conductscience.org/library/papers/39487018 | PubMed |
| 39196368 | Preventing perinatal HIV acquisition; current gaps and future perspectives. | Curr Opin HIV AIDS | 2024 | https://conductscience.org/library/papers/39196368 | PubMed |
| 37612306 | Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection. | Expert Rev Clin Pharmacol | 2023 | https://conductscience.org/library/papers/37612306 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| BCRP1 | 644079 | PubTator's text mining | https://conductscience.org/library/genes/644079 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CTSA | 5476 | PubTator's text mining | https://conductscience.org/library/genes/5476 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34864950
GET https://conductscience.org/api/papers/v1/34864950/references?page=2